Where does Nacuity Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Nacuity Pharmaceuticals, Inc. ranks #32,570 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Nacuity Pharmaceuticals, Inc. hold?

Nacuity Pharmaceuticals, Inc. holds 8 US utility patents granted between 2017 and 2025, spanning 5 technology areas.

What is Nacuity Pharmaceuticals, Inc.'s Innovation Score?

Nacuity Pharmaceuticals, Inc. has an Innovation Score of 36.8 out of 100 (top 45% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nacuity Pharmaceuticals, Inc. focus on?

Nacuity Pharmaceuticals, Inc.'s top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 6 patents. Grants appear in 5 CPC subclasses total.

Is Nacuity Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Nacuity Pharmaceuticals, Inc.'s recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Nacuity Pharmaceuticals, Inc.'s patents?

Nacuity Pharmaceuticals, Inc.'s patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Nacuity Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Nacuity Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Nacuity ranks #32,570 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.

#32,570
of 49,997 US assignees by volume: Top 45%
by Innovation Score (36.8/100): 18.8
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32570 · US Corporation #32,570 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,570/49,997
PHOTO-FINISH Nano 2 0 Business…
CPC-NARROW C07C · 5 areas
INNOV-THIN 36.8/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nano 2.0 Business Press, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Hydrokinetic Energy · near

37
Fender Musical… · near

37
Lucifer Lighting · near

37
Nacuity Pharmaceutic… · this assignee

37
Sakti3 · near

37
3D Lighting… · lowest

7

What this shows Nacuity's Innovation Score is 36.8/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Nacuity's grants concentrate

Nacuity Pharmaceuticals, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 75% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2017. By volume, Nacuity sits between Nuvinair, LLC and Nanomedical Diagnostics, Inc..

Nacuity's three-year grant acceleration

Nacuity Pharmaceuticals, Inc. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nuvinair

8
NVT

8
NYC Designed Insp…

8
NZP UK

8
Nano 2 0 Business…

8
Nano Composite Pr…

8
Nano-master

8
Nanomedical Diagn…

8
Nacuity Pharmaceu… ◀

8

What this shows Nacuity holds 8 patents at rank #32,639, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nacuity

By rank, the assignees closest to #32,639 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in Nacuity's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nacuity, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Lucifer Lighting Company 37 Fender Musical Instruments Corporation 37 Sakti3, Inc. 37 Hydrokinetic Energy Corp 37

Nacuity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Nacuity Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	12.5%
2018	1	12.5%
2020	1	12.5%
2021	1	12.5%
2023	3	37.5%
2025partial year	1	12.5%

Which technologies does Nacuity Pharmaceuticals, Inc. patent most?

C07C - Acyclic OR Carbocyclic Compounds 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

C07D - Heterocyclic Compounds 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#32,570

of 49,997 tracked assignees

Innovation Score

36.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Nacuity Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Nacuity Pharmaceuticals, Inc.'s lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 75% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #32,570 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Nacuity Pharmaceuticals, Inc. against Nuvinair, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.